SUNNYVALE, CA--(Marketwire - July 01, 2008) - Conformia, the market leader of product and process lifecycle management (PPLM) solutions for life sciences, today announced the U.S. Food and Drug Administration’s (FDA) Office of Pharmaceutical Sciences (OPS) has asked the Company to expand its Cooperative Research and Development Study (CRADA) focusing on process and product development to 25 companies. The CRADA Research Study is helping to uncover the challenges facing pharmaceutical, biotechnology, and generics process/product development organizations as they attempt to implement the ICH Quality Vision (ICH Q8, Q9, Q10) across the product and process lifecycle.
